HSV529 Vaccine in HSV-2 Seropositive Adults

NCT02571166 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Herpes Simplex Virus 2

Interventions

BIOLOGICAL: HSV529
DRUG: Valacyclovir

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]
[object Object]